TrialThe New England journal of medicine2019
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Matthew D Hellmann et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,672 papers cite itlatest 60 shown
this paperpooled ittrialcites it